Back to Newsroom

BIND Therapeutics to Present at Biotech Showcase 2016

CAMBRIDGE, Mass.–(BUSINESS WIRE)– BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine company developing targeted and programmable therapeutics called ACCURINS®, today announced that Andrew Hirsch, BIND’s president and chief executive officer, will present at the 8th Annual Biotech ShowcaseTM 2016 in San Francisco on Monday, January 11, 2016 at 4:00 p.m. PT.

Interested parties may access a live webcast of the presentation by visiting the BIND Therapeutics website at The webcast will be archived on the BIND Therapeutics website following the event for one week.